This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atrialfibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options. What is AtrialFibrillation?
(MedPage Today) -- It was safe to start direct oral anticoagulant (DOAC) therapy without delay after acute ischemic stroke in people with atrialfibrillation (Afib), according to the OPTIMAS randomized trial. Stroke survivors randomized to early.
18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrialfibrillation (AFib) who are at an increased risk of stroke. A statistically significant lower number of fatal or disabling strokes with Amulet (22 vs. 39). vs. 90.9%).
(MedPage Today) -- Cryptogenic stroke survivors who went on to get an insertable cardiac monitor (ICM) had a similar risk of recurrent stroke whether or not any atrialfibrillation (Afib, AF) ever turned up on monitoring, an observational study.
People who regularly floss their teeth (one or more times per week) may lower their risk of stroke caused by a blood clot traveling from the heart and a stroke associated with an irregular heartbeat such as atrialfibrillation (AFib).
(MedPage Today) -- Oral anticoagulation (OAC) was no better than low-dose aspirin for secondary stroke prevention in people with left atrial cardiopathy absent evidence of atrialfibrillation (Afib or AF), the ARCADIA trial showed. Recurrent strokes.
A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
Atrialfibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. In the U.S.,
he utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrialfibrillation (AFib) is the focus of a State-of-the-Art Review published Jan. 8 in JACC: Clinical Electrophysiology.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. 1 Approximately 33 million patients worldwide are living with AFib. adult population.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
(MedPage Today) -- Very elderly people with nonvalvular atrialfibrillation (Afib) got the same stroke prevention benefits from edoxaban (Savaysa) and apixaban (Eliquis), though one drug was associated with more major bleeding in a comparative.
Rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack (TIA) in patients younger than 65 with nonvalvular atrialfibrillation (AFib) and low risk for stroke, according to results from the BRAIN-AF trial.
Affecting 60 million people worldwide 1 , the prevalence of atrialfibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic risk factors 2. Today, 40% to 60% of patients with AFib are either not prescribed anticoagulants or are undertreated 4.
A BMJ study out of Denmark provided alarming new insights into atrialfibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFib heart failure and stroke prevention. Danish people who didn’t have AFib at baseline (45-95yrs, 48yr avg, 51.7% in 2011-2022.
At the forefront of PowerPlugs is AFib Detection , a PowerPlug that discreetly monitors your heart rhythm every night to detect signs of AtrialFibrillation (AFib). Ultrahuman Ring AIR is the first smart ring in the world to offer AFib detection. AFib is the most common type of irregular heart rhythm or arrhythmia.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrialfibrillation (AFib). Today, approximately 8 million Europeans over the age of 65 are living with AFib, a number expected to double over the next 30 years.
Looking at specific substances in the blood of people with atrialfibrillation, a type of irregular heartbeat, could help identify who's at risk for a stroke despite taking blood-thinning medication to prevent one, new research suggests.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
According to Dr. Roopinder Sandhu, MD, MPH, atrialfibrillation (Afib) is the most common heart rhythm disorder encountered in clinical practice, and the leading cause of stroke in older individuals.
Edoxaban was comparable to warfarin in preventing stroke or systemic embolism and intracardiac thrombus in patients with non-valvular atrialfibrillation (AFib) within three months after bioprosthetic valve surgery, based on preliminary findings from the ENBALV trial presented at AHA 2024.
It is estimated that more than 12 million people in the United States will have AtrialFibrillation, or AFib in 2030. If left untreated, this erratic heartbeat can disrupt blood flow and lead to serious life-threatening issues like stroke or heart failure.
Left atrial appendage closure (LAAC) in patients at moderate to high risk for stroke who were undergoing catheter atrialfibrillation (AFib) ablation resulted in significantly less bleeding compared with oral anticoagulation, based on findings from the OPTION trial presented at AHA 2024 and simultaneously published in NEJM.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4 Int J Stroke. In: AF Symposium.;
(MedPage Today) -- For some patients with atrialfibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) appeared to offer better prevention of stroke and thromboembolic events compared with warfarin, without.
(MedPage Today) -- Adding prophylactic left atrial appendage (LAA) closure to planned cardiac surgery was linked to lower stroke risk for patients without atrialfibrillation (Afib, or AF), based on a meta-analysis. Pooling six observational and.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
Research Highlights: In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline, stroke or transient ischemic attack (TIA) in people younger than age 65 who had atrialfibrillation (AFib).
In this installment of AtrialFibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to previous guidelines.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. If you or someone you know is living with AFib, understanding the condition and how to prevent attacks is crucial. What Is AFib? How Do You Know If You Have AFib?
Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment. Patients with NVAF deemed appropriate for LAAX to reduce the risk of stroke and systemic embolism, will participate in this research effort.
One-time screening for atrialfibrillation (AFib) using a 14-day, electrocardiographic (ECG) patch monitor in individuals aged ≥70 years did not reduce rates of bleeding or stroke, based on results from the GUARD-AF trial.
Asundexian was associated with a higher incidence of stroke or systemic embolism, but less major bleeding, compared with apixaban among patients with atrialfibrillation (AFib) who were at high risk for stroke, based on findings from the OCEANIC-AF trial presented at ESC Congress 2024 in London and simultaneously published in The New England Journal (..)
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
The ACC has issued new guidance on practical approaches for arrhythmia monitoring after stroke, offering clinicians tailored strategies to improve post-stroke care by identifying and managing atrialfibrillation (AFib) and other arrhythmias linked to recurrent stroke risk.
Her Apple Watch suddenly told her that she is in atrialfibrillation. Patients with healthy AV nodes who are not on AV nodal blockers and who are not hyperkalemic should have a rapid ventricular response if they have paroxysmal Atrialfibrillation. I focus my comment on a few additional aspects regarding new AFib.
Abstract Introduction Atrialfibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
(MedPage Today) -- CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrialfibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the randomized OPTION trial showed.
Detection of Irregular Heart Rhythms Devices such as the Apple Watch or Fitbit Sense can detect irregular heart rhythms, including atrialfibrillation (AFib). These early warnings are critical, as AFib increases the risk of stroke and other heart-related complications.
Direct oral anticoagulants (DOACs) reduce stroke risk in patients with device-detected atrialfibrillation (DD-AFib) but increase major bleeding risk. The time to benefit (TTB) and time to harm (TTH) are not well quantified.
Examples of cardio embolic stroke etiology include: 1. AtrialFibrillation 2. Cardiomyopathy with mural thrombus 3. Patent Foramen Ovale 4. Severe calcific Aortic (valve) Stenosis 5. Mechanical prosthetic valve Severe carotid artery stenosis is also implicated in embolic stroke. AFib can come and go.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content